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Abstract
Purpose Recommendations addressing school screening
for adolescents with idiopathic scoliosis are contradictory.
Consequently a critical evaluation of the methodological
quality of available systematic reviews, including those upon
which these recommendations are based, was conducted.
Methods Articles meeting the minimal criteria to be con-
sidered a systematic review were included for a best evidence
synthesis, umbrella review of secondary studies. The primary
outcome measure was ‘‘any recommendation addressing the
continuation, or not, of school screening programs’’. Multiple
general bibliographic databases, guideline registries, as well
as websites of institutions were searched. The AMSTAR tool
was used to critically appraise the methodology of included
reviews. Venn diagrams were created to examine potential
overlaps across included papers within different reviews.
Results Six reviews undertaken between 2002 and 2011,
scored as moderate to low quality, were included. The 2012
US Preventive Services Task Force recommendation
against screening was found to be based on an outdated
(2004) low-quality review, whilst two higher quality and
more recent (2009 and 2010) reviews support the contin-
uation of school screening programs.
Conclusions As the existing recommendations supporting
screening are based on moderate quality evidence whilst
the recommendations against screening are based on low-
quality evidence, the latter recommendations appear to be
both unconvincing and methodologically invalid.
Keywords Idiopathic scoliosis  Screening 
Adolescents  Recommendations  Systematic reviews 
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Background
Adolescent idiopathic scoliosis (AIS) is considered by some
authors to be a condition fulfilling the criterion of being an
‘‘important healthcare problem meeting the requirements
for a screening program’’ [1, 2]: the prevalence is estimated
to be at 2–3 % of adolescents aged 10–16 years, the con-
dition, depending on the severity of the deformity and with
individual variations, affecting both physical and psycho-
logical functioning and with pain and decreased quality of
life in the long term [1]. Other authors, however, classify
the condition as not meeting this criterion [3, 4].
The mandate for school-based screening programs for
scoliosis is highly controversial [5–8] and is an issue that is
strongly debated [9–14]. National institutions and profes-
sional organizations in different countries and/or states
currently either opt for mandatory screening [15], recom-
mendation [2, 16–20] or simply discourage screening [1, 3,
6, 21–23]. Even very recent recommendations are contra-
dictory [2, 21, 23, 24]. A summary and chronology of the
recommendations made by different organizations in dif-
ferent countries since 1979 can be found in Table 1.
Unexpectedly, the ‘update’ document, based on evi-
dence published prior to 2003 [30], has remained the
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background for the 2012 US Preventive Services Task
Force (USPSTF) recommendations [25], despite both
qualitative [16, 35] and then quantitative [32] systematic
reviews favoring screening being published in 2009 and
2010. Conversely, the 2011 review prepared for the United
Kingdom National Screening Committee (UK NCS) as an
update of the USPSTF 2004 review [30] provides conclu-
sions that discourage screening [1].
Consequently, the recommendations, including those
that are evidence-based, remain controversial, with differ-
ent reviews reaching different conclusions. Hence an ana-
lysis of the content and quality of these reviews is urgently
needed to help health care professionals as well as service
users and commissioners make appropriate policies and
evidence-based decisions [36, 37].
Our objective was to critically evaluate the methodo-
logical quality of current published systematically devel-
oped reviews (including those from systematically
developed recommendations), that address school screen-
ing for scoliosis.
Methods
We followed the PRISMA statement for systematic
reviews [38] for conducting and reporting this study.
Criteria for inclusion in the review
Types of studies
Eligible studies considered included systematic reviews of
any types of primary studies. Papers were considered as
systematically developed reviews if they reported on
methods to identify and select papers, and which critically
appraised relevant evidence [39]. These minimal criteria
also applied for reviews of evidence, prepared for, or
reported in, systematically developed clinical practice
guidelines and recommendations [40]. Exclusion criteria
were narrative reviews, expert opinions, letters to the editor
and editorials.
The eligibility criteria defined for population, exposure
and outcomes are presented in Box 1.
Search strategy
Given the fact that the USPSTF formulated their recom-
mendations based on evidence available between 1994
through 2002, our search was limited, where applicable, to
the time period from 01 January 2003 to the most current
available date. The databases were last searched between
30 May and 19 August 2013. An updated PubMed and
reference list search was also conducted on retrieved
papers on 02 November 2013. The search was limited to
articles with at a minimum an abstract in English. Dat-
abases searched as well as the order of searching are shown
in Box 2.
Table 1 Chronology and methods of development of the recom-
mendations addressing school screening for scoliosis
Year(s) Institution Statement Type Reference
1970s–
80s
School screening mandatory/voluntary in the
USA
[4]
1979 CTFPHE ? EB [26]
1993/
1996
USPSTF ? EB [27, 28]
1994 CTFPHE ? EB [29]
2002 NHMRC NO EB [3]
2004 USPSTF NO EB [30]
2005 Italian guidelines YES CB [18]
2007 SOSORT YES CB [19]
2007 Californiaa YES EC [15]
2008 SRS, AAOS,
POSNA, AAP
YES CB [17, 31]







2011 AANP YES CPE [33]
2011 AAFP NOb EB [23]
2011 ICSI NO/YESc EB/CB [34]
2011 SOSORT YES CB/EBd [20]
2012 UK NSC NO EB [21]
2012 USPSTF NO EBe [24, 25]
2013 SRSf YES CB/EB [2]
NO recommendation against, ? unknown effectiveness/insufficient
evidence to recommend for or against, YES screening recommended,
EB evidence-based, CB consensus-based, OB opinion-based, EC
educational code, SR systematic review, HTA health technology
assessment, CPE continuous professional education paper, CTFPHE
Canadian Task Force on Periodic Health Examination; USPSTF US
Preventive Services Task Force, NHMRC National Health and Med-
ical Research Council, Australia, SOSORT Society for Spinal
Orthopaedic and Rehabilitation Treatment, SRS Scoliosis Research
Society, AAOS American Academy of Orthopedic Surgeons, POSNA
Pediatric Orthopedic Society of North America, AAP American
Academy of Pediatrics, MaHTAS Ministry of Health Malaysia, Health
Technology Assessment Section, ICSI Institute for Clinical Systems
Improvement, AANP American Academy of Nurse Practitioners,
AAFP American Academy of Family Physicians, UK NSC UK
National Screening Committee
a Department of Education
b Following USPSTF
c USPSTF and SRS positions considered
d Each recommendation graded according to a ‘‘strength of evi-
dence’’ and/or ‘‘strength of recommendation’’ classification
e Refers to 2004 evidence update
f SRS International Panel
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The search terms ‘‘scoliosis’’ and ‘‘screening’’ were
used to search the registries of systematic reviews,
guideline databases and portals of screening recommen-
dations. In PubMed the MeSH terms ‘‘scoliosis’’ and
‘‘mass screening’’ as well as the free terms ‘‘scoliosis’’
and ‘‘screening’’ were used together with the filters
‘‘review’’ and ‘‘meta-analysis’’. For other bibliographic
databases corresponding search terms and limits were
used. Additionally, the reference lists of papers included
for full text analysis as well as other publications in this
area were handsearched. Authors of published papers and
reviews in progress were not contacted, as our aim was to
assess published reviews.
Study selection
We independently conducted the searches as well as the
initial selection of studies by their title and/or abstract. Full
papers were then examined for eligibility. Disagreements
were resolved by discussion. The PRISMA search flow for
the selection of included studies is shown in Fig. 1.
Methodological assessment
The ‘‘Assessment of Multiple Systematic Reviews’’, AM-
STAR measurement tool [41] was used to assess the
methodological quality of included reviews. The AMSTAR
Box 1 Criteria for inclusion in the review regarding population, exposure/issue and outcomes (PEO)
Inclusion criteria Exclusion criteria
Population School children, both girls and boys, with no geographical or
other (e.g. societal, racial, cultural) restrictions, in age period
associated with the risk of development of AIS, typically
10–12 years of age; however, no strict age criteria were defined
Papers including other populations of children, e.g. with co-
morbidities, such as Duchenne muscular dystrophy
Exposure
or issue
Any reviews addressing ‘school screening for AIS’ Papers addressing other screening programs, that did not
exclusively address screening tests for adolescent idiopathic
scoliosis, e.g. general health examinations; screening
programs for other types of scoliosis were also excluded (e.g.
adult scoliosis)
Outcomes Primary outcome: any recommendation that stated to
recommend screening or not to recommend screening, i.e. a
‘‘yes’’ or ‘‘no’’ with regard to the authors‘ recommendations;
also any secondary outcomes, if analyzed in the retrieved
reviews
Not specified
Box 2 Databases searched and the order of searching
Databases of systematic reviews, guideline registries and databases with separate indexing of systematic reviews and guidelines
The Centre for Reviews and Dissemination databases—DARE, HTA, NHSEED, Cochrane Database of Systematic Reviews (CDSR), Joanna
Briggs Institute, Campbell Library, Cochrane Effective Practice and Organisation of Care (EPOC) Group, the AHRQ databases and
resource lists from USPSTF, AHRQ Evidence-based Practice Centers (EPC Reports) and National Guideline Clearinghouse, PEDro,
INAHTA, TRIP
Websites of institutions
USPSTF, CTFPHC, NHMRC, UK Screening Portal/ UK NSC Policy Database, Scottish Intercollegiate Guideline Network (SIGN), National
Institute for Clinical Excellence, UK (NICE)
General bibliographic databases
MEDLINE through PubMed, Web of Science and SportsDiscus through EBSCO, Google Scholar
Gray literature—registered protocols, reviews in progress, guidelines in development and registered titles
PROSPERO, CDSR, the USPSTF registry of the topics in progress, the CTFPHC protocols, HSR Project Database, NICE, AHRQ EPC
Reports database (for the EPC Reports in Progress), HSRProj Database, the NHMRC website and the Systematic Review Data Repository
(SRDR) database, the Conference Proceedings Citation Index—Science from the Web of Knowledge
For abbreviations not explained here see Table 2
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comprises 11 quality criteria (Table 3). The items are
scored ‘‘yes’’, ‘‘no’’, ‘‘cannot answer’’, or ‘‘not applicable’’.
The maximum score is 11. Scores 0–4, 5–8 and 9–11
indicate low-, moderate- and high-quality reviews,
respectively [42]. The appraisal was conducted indepen-
dently by MP and JB-S, using guides for scoring AMSTAR
questions [41, 42]. Disagreements were resolved by dis-
cussion and compromise.
Further, the quality analysis of the USPSTF review
[30] was expanded with a search for information
addressing AMSTAR questions in related USPSTF doc-
uments, referenced in the appraised paper [27, 28, 43, 44].
When appraising the UK NSC [1] and NHMRC [3]
reviews, the supplementing documentation was also
evaluated [45–48].
Overlap across studies
The reference lists of the included reviews were compared
and Venn diagrams were created to examine potential
overlaps across included papers within different reviews
(Figs. 2, 3, 4, 5, Table A3—supplementary material).
Findings
Search results
From a total of 224 papers, six articles met the criteria for
inclusion within the analysis: two quantitative systematic
reviews [1, 32] one of which included a meta-analysis
[32] and four systematic analyses of evidence which were
part of [3, 16, 18] or supplementing [30] recommendation
documents. Two further publications were duplicates [35,
49]. One supplement [48] was excluded as it duplicated the
content of the resource review [3]. The included papers are
characterized in Table 2. Excluded publications are listed,
with reasons for exclusion, in Table A2 (supplementary
material).
Gray literature
A protocol [50] as well as an information statement was
found [2] together with a reference to one systematic
review being in press [51]. However, as the paper was not
published at the time of writing this manuscript, it was not
Fig. 1 PRISMA flow diagram of included studies. 1 CRD York
(DARE, HTA, NHSEED), n = 72, Cochrane CDSR, n = 35, Joanna
Briggs Institute, n = 1, Campbell Library, n = 0, PEDro, n = 17,
TRIP, n = 14, PubMed/MEDLINE, n = 109, Web of Science,
n = 203, SportsDiscus, n = 13, GoogleScholar, n = 104; 2 regis-
tries, websites of institutions: Cochrane EPOC Group, n = 0,
USPSTF, n = 3, AHRQ EBP Reports, n = 0, National Guideline
Clearinghouse, n = 25, INAHTA, n = 1, CTFPHC, n = 1, SIGN,
n = 0, NICE, n = 15, UK NSC, n = 5, NHMRC, n = 4, HSRProj,
n = 2, PROSPERO, n = 2; hand searching of reference lists, n = 2;
3 some full text papers were excluded for more than one reason
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included in the analysis. The review is, however, listed in
Table A2 (appendices)—the list of excluded papers.
Quality analysis
Three papers [3, 16, 32] were of moderate and three [1, 18,
29] of low quality, respectively. The review by Sabirin
et al. [16] and the meta-analysis by Fong et al. [32]
received the highest scores of 6 points. The NHMRC [3]
and the UK NSC [1] reviews received scores of 5 and 4,
respectively. The Italian guidelines [18] as well as the
USPSTF review [30] received the lowest scores of 2 points.
Table 3 provides details of the AMSTAR quality assess-
ment, with explanations regarding the scoring decisions.
Overlap across included reviews
Included reviews differed substantially with regard to both
the numbers as well as the choice of included papers. The
USPSTF evidence analysis [30] included 10 studies (with
14 % of reports included in all reviews), while Sabirin
et al. [16] and Fong et al. [32] included 28 and 36 papers
(41 and 52 % of reports included in all analyzed reviews),
respectively. The USPSTF and the NHMRC recommen-
dations that are based on 10 and 13 papers, respectively,



















Fig. 4 Venn diagram illustrating the overlap of older reviews
included in current recommendations from NHMRC, USPSTF, and
Italian guidelines. Numbers and percentages inside the circles show
the overlap of studies included in the four reviews. Percentages
outside the circles illustrate the percentage of all 40 studies included
in each of the three reviews. Total n = 40 (100 %). NHMRC –
National Health and Medical Research Council, Australia; USPSTF
U.S. Preventive Services Task Force; Italian guidelines—‘‘Italian
guidelines on rehabilitation treatment of adolescents with scoliosis or
other spinal deformities’’; 1 quality assessment of four articles is




























Fig. 2 Venn diagram illustrating the overlap of papers included in
the USPSTF report and the more recent systematic reviews. Numbers
and percentages inside the ellipses show the overlap of studies
included in the four reviews. Percentages outside the ellipses illustrate
the percentage of all 109 studies included in each of the four reviews.
Total n = 109 (100 %). USPSTF—the US Preventive Services Task
Force; MaHTAS Health Technology Assessment Section, Ministry of
Health Malaysia; UK NSC the UK National Screening Committee; 1

























Fig. 3 Venn diagram illustrating the overlap of papers included in
the NHMRC report and the more recent systematic reviews. Numbers
and percentages inside the ellipses show the overlap of studies
included in the four reviews. Percentages outside the ellipses illustrate
the percentage of all 113 studies included in each of the four reviews.
Total n = 113 (100 %). NHMRC National Health and Medical
Research Council, Australia; MaHTAS Health Technology Assess-
ment Section, Ministry of Health Malaysia; UK NSC the UK National
Screening Committee; 1 quality assessment for four key articles
documented in the report; 2 Fong et al. is included in the UK NSC
review
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The Italian review covering a similar time period is
based on 21 papers, of which only one overlaps with the
USPSTF and none with the NHMRC recommendations,
respectively (Fig. 4).
Further, the 2011 UK NSC review, referring to 53
publications, overlaps with only two papers in the MaH-
TAS review but does not overlap with any papers included
in the meta-analysis by Fong et al. (although this paper is
cited). In brief the three papers, developed within similar
time frames, only have 2 or 2 % of included studies that
overlap (Fig. 5).
Table A3 (supplementary material) shows how the
studies included in the analyzed reviews were contrasted in
order to produce the Venn diagrams.
Discussion
Brief summary of results
Searching process and selection of the reviews
Comprehensive literature searches and selection of
retrieved papers (Box 2, Fig. 2, Table A2—supplementary
material) resulted in including six systematic reviews [1, 3,
16, 18, 30, 32], of which five [1, 3, 16, 18, 30] were con-
ducted in the process of systematically developing rec-
ommendations. Full text analyses of a further 34 papers
resulted in excluding 15 reviews addressing the subject
matter, but not fulfilling the minimal criteria for a sys-
tematic review. Nineteen full texts were also excluded for
other different reasons (Fig. 1, Table A2—supplementary
material). Therefore, to our knowledge this study presents
the first comprehensive and in-depth analysis of systematic
reviews regarding screening programs for adolescents for
idiopathic scoliosis.
Quality and recency of the reviews
Overall, the quality of systematic reviews ranged from the
comparatively recent (2009) moderate quality (AMSTAR
score 6) Fong et al. [32] and Sabirin et al. [16] through to the
outdated (2002) moderate quality NHMRC, reviews [3], to
the poor quality recent (2011) UK NSC [1] and outdated
(2004, nonetheless used for recent (2012) recommendations
[24, 25] ) USPSTF [30] and Italian (2005) [18], reviews.
The reviews which supported the recommendation for
school screening [16, 18, 32] as well as those recommending
against screening [1, 3, 30] are based on different papers
selected for inclusion (Figs. 2, 3, 4, 5) [and thus on different
evidence or assumptions of the absence of evidence
(Table 2)]. Further, regardless of the different time limits
used within searches, the reviews also differed significantly
with regard to the databases selected, and other resources,
searched (Table 2). Moreover, significant heterogeneity was
found within the reviews as follows: different research
designs were considered (prospective trials and retrospective
observational studies, systematic reviews, editorials), which
were, except in the Fong et al. [32] meta-analysis, analyzed
separately (Table 2). Conclusions were based on different
criteria as follows: the set of criteria for appraising—feasi-
bility, effectiveness and appropriateness of a screening
program [1, 3], accuracy of screening tests [16, 18, 32],
treatment effectiveness as a criterion justifying the need for
screening [16, 18, 30] and cost-effectiveness [1, 16].
Methodology issues
The reviews included within this study were heteroge-
neous, both with regard to the research questions asked as
well as the methodology used for their development.
Therefore, we conducted an umbrella review, as described





















Fig. 5 Venn diagram illustrating the overlap of papers included in
the more recent systematic reviews. Numbers and percentages inside
the circles show the overlap of studies included in the three reviews.
Percentages outside the circles illustrate the percentage of all 40
studies included in each of the three reviews. Total n = 102 (100 %).
UK NSC the UK National Screening Committee; MaHTAS Health
Technology Assessment Section, Ministry of Health Malaysia; 1 this
review also included the systematic review by Fong et al.; 2 UK NSC
review cites Fong et al.
1 This is a review which ‘‘focuses on a broad condition or problem
for which there are competing interventions and highlights reviews
that address these interventions and their results’’ identifies compo-
nent reviews, but not primary studies, provides quality assessment of
studies within component reviews and/or of reviews themselves
component reviews, with graphical and tabular synthesis with
narrative commentary, and analysis of what is known, what remains
unknown, and with recommendations for practice and future research,
[52].
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primary studies were considered. It is important to note that
the term ‘‘umbrella review’’ is also used by some authors
[e.g. 54] to describe a systematic review of high-quality
systematic reviews which is not the case in this evaluation.
Discussion and critique of included reviews
Higher quality systematic reviews
Three of the systematic reviews were found to be of
moderate quality; Fong et al. [10], Sabirin et al. [16] and
NHMRC [3].
Fong et al. [32] (2010) reported that only 17 % of the
primary studies included within their meta-analysis of
retrospective cohort studies found screening to be inef-
fective. The authors advocate for school screening, but
recommended that the forward bend test should not be used
alone within screening programs and that large, retro-
spective cohort studies are needed to better study the reli-
ability of screening tests. As regards the studies included
for analysis, the results of the Fong review only overlaps
partially with the Sabirin et al. [16] study, but shows no
overlap with the UK NSC 2011 review [1] (Fig. 5) and the
older reviews reported by the USPSTF [30] (Fig. 2) and
NHMRC [3] (Fig. 3). The conclusions from the Fong study
were in part based on different evidence as well as different
assumptions to the other reviews. Whilst the AMSTAR
score for this meta-analysis is only of moderate quality (6),
the report does meet the essential criteria of a good quality
quantitative systematic review (Tables 2 and 3).
MAHTaS (2009) systematic review by Sabirin et al. [16]
included a methodological assessment of individual studies
as well as a cost–utility analysis. The authors recom-
mended continuation of the screening program in Malaysia,
under specific conditions: in high-risk group of 12-year-old
girls, using combination of screening tests, and with well-
secured training, manpower, good referral system, treat-
ment and funding. The review was clearly reported (AM-
STAR score of 6 (Table 3); however, we encountered
difficulties with regard to the assessment of question 8
within AMSTAR: unfortunately, only the results of 8 out of
24 papers appraised, utilizing the CASP tool were reported.
Furthermore, studies of different types designs were
included and analyzed separately (Table 2), which in some
instances may diminish the internal validity of the review
as well as the strength of the conclusions.
The NHMRC (2002) document [3] recommends against
screening for scoliosis. All the criteria for conducting a
systematic review are described in detail. Moreover, unlike
the other reviews evaluated, a defined methodology for the
quality assessment of systematic reviews was provided.
Nonetheless, the meta-analysis included in the systematic
review of evidence regarding screening for scoliosis [55],
and 8 out of 12 included primary studies, were only dis-
cussed descriptively (Table 2), without conducting a criti-
cal appraisal of their quality. Moreover, several other
eligible primary studies were not included for analysis
(Fig. 4).
The NHMRC report has not been updated since 2002,
while the AMSTAR does not reflect the recency of the
analyzed reviews. Also, the NHMRC review [3] was not
developed according to the subsequently (2009) improved
NHMRC evidence hierarchies [56].
In fact, most of the six reviews analyzed matched nei-
ther the improved (2009) NHMRC [56], nor the new
(2011) Oxford Centre for Evidence-Based Medicine
(OCEBM) levels of evidence hierarchy (Levels of Evi-
dence 2 [57]), with the exception of Fong et al., which can
be classified as a level 3 evidence in the OCEBP classifi-
cation (Box 3).
Box 3 Definitions of evidence hierarchy for diagnostic accuracy and
screening interventions described by different organizations
Diagnostic and monitoring tests/diagnostic accuracy
The new (2011) Oxford Centre for Evidence-Based Medicine
(OCEBM) levels of evidence hierarchy (Levels of Evidence 2
[56] ) states that ‘‘systematic review of cross sectional studies
with consistently applied reference standard and blinding’’ are
step 1 (level 1) of evidence and consequently individual studies
are level II evidence;
The improved (2009) Australian NHMRC ‘‘Additional Levels of
Evidence and Grades for Recommendations for Developers of
Guidelines’’ document [55], providing hierarchy of evidence for
different types of research questions, defines level II evidence as
‘‘a study of test accuracy with: an independent, blinded
comparison with a valid reference standard, among consecutive
persons with a defined clinical presentation’’, and systematic
reviews of level II studies are level I evidence;
Both classifications list case–control studies (level IV—OCEBM,
level III-3—NHMRC) but not retrospective cohort studies.
Screening interventions (both OCEBM and NHMRC)
Systematic reviews of prospective, randomized controlled trials
(RCTs)—level I evidence;
Individual RCTs—level II evidence;
Lower quality reviews
The UK NSC review (2011) [1], prepared as an update of
the 2004 USPSTF analysis [30], sustains the recommen-
dations against screening. The report scored 4 with AM-
STAR (low quality review, Tables 2 and 3). The authors
addressed several criteria regarding the mandate for a
screening program, including the cost-effectiveness of the
programs, as well as the effectiveness of conservative and
surgical treatment. The observational, experimental stud-
ies as well as the systematic reviews included within this
2580 Eur Spine J (2014) 23:2572–2585
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paper discussed diverse aspects of scoliosis management
and are described broadly and narratively. Eligibility cri-
teria for paper inclusion are not reported. The lists of 470
retrieved reports [45–47] supplement the review, which
factually discusses 53 papers but no list of excluded
studies is provided. The review reports on search limits
from 2002 to 2011, but single older studies are also
included. Thus, it would be difficult to judge how the
studies described in the review were chosen. Further,
while the hierarchy of evidence level is suggested—the
designs of the discussed papers are reported, crucially the
included studies are not critically appraised. Without
knowledge of the methodological quality of included
papers it is very difficult to come to a conclusion as to
whether the results of this review can be applied to
practice and whether the recommendations are truly valid
and evidence-based.
The USPSTF resource review for the 2012 USPSTF
recommendations against screening [24, 25]—the 2004
‘‘Brief Evidence Update’’ [30], recommending against
school screening—has been shown to be of poor quality,
with an AMSTAR score of 2. The ‘‘critical’’ ‘‘key ques-
tion’’—‘‘Is there new evidence that scoliosis treatment
leads to better health outcomes if applied at an early stage’’,
was answered by analyzing one RCT, three reports of a
large retrospective observational studies, one case series
and a meta-analysis of studies from between 1975 and 1995
on the effectiveness of conservative treatments [55]. No list
of excluded studies was provided, and crucially no meth-
odological quality appraisal of their included studies was
conducted. Further, the search period is outdated
(1994–2002) and the literature search was not comprehen-
sive (Fig. 4). Consequently, this review scored a low value
of 2 with AMSTAR (Table 3). Whilst the USPSTF did
Table 3 AMSTAR ratings for included reviews
Reference AMSTAR questionsa Total Yes Overall qualityb
1 2 3 4 5 6 7 8 9 10 11
[3] Y CA Y Y N Y Y N NA N N 5 Moderate
[29]c Y CA Nd N N Y N N NA N N 2 Low
[18] Y CA Ne Y N N Nf Ng NA N N 2 Low
[16] Y Y Y Y Y Y CAh Ni NAj N N 6 Moderate
[31] Y Y Y N N Y Nk Ng Y Yl N 6 Moderate
[1] Y CA Y Y N Y N Ng NA N N 4 Low
Y yes, N no, CA cannot answer, NA not applicable
a Questions [38]: ‘‘1 Was an a priori design provided?, 2 Was there duplicate study selection and data extraction?, 3 Was a comprehensive
literature search performed?, 4 Was the status of publication (i.e. grey literature) used as an inclusion criterion?, 5 Was a list of studies (included
and excluded) provided? 6 Were the characteristics of the included studies provided?, 7 Was the scientific quality of the included studies assessed
and documented?, 8 Was the scientific quality of the included studies used appropriately in formulating conclusions?, 9 Were the methods used to
combine the findings of studies appropriate?, 10 Was the likelihood of publication bias assessed?, 11 Were potential conflicts of interest
included?’’
b Scores of 0–4 indicate that the review is of low quality, 5–8 of moderate quality and 9–11 of high quality [41]
c As the 2004 USPSTF statement, and the subsequent Guides, were based on, and referred to, the 2004 ‘‘Brief Evidence Update’’, we focused our
appraisal on that document, and referred to other related documents only if indicated/referenced to in the ‘‘Brief Evidence Update’’: (1) [27], pp.
xlvii–liv, 517–529, (2) [26, 42]; (3) [43]
d The 1996 document [27] provides sufficient information for a Y, but the 2004 update reports only on databases searched, with no information
on supplementary strategies
e Only one electronic source reported; the phrase ‘‘internet sources’’ does not fulfil the criteria of AMSTAR scoring
f A hierarchy of study quality was used, and the authors report on low quality of analyzed papers, but no quality assessment is documented
g Rated ‘‘N’’ in accordance with AMSTAR criteria, because item 7 rated ‘‘N’’
h Quality of 8 (7 cross-sectional and 1 case–control), out of 28 included studies, were assessed with CASP tool, but remaining 16 cross-sectional,
2 cost-effectiveness, 1 before-and-after study, and 1 study described as cross-sectional/case series, were not; also, answers to the CASP questions
are reported without an elaboration; therefore, according to the instructions for AMSTAR [38], we rated this item with ‘‘CA’’
i A discussion regarding the quality of included studies is provided, but we rated ‘‘N’’, because item 7 rated ‘‘N’’
j The protocol of the review includes information about planned analysis for heterogeneity, but no information is provided in the actual report
k The authors did discuss the scientific quality of the included studies, but they did not use any quality scoring tool or a checklist separately for
each of the included studies, thus we rated ‘‘N’’
l Funnel plots are discussed in the article and included in the thesis [48], which we excluded as a duplicate; the remaining contents of these two
papers are identical
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elaborate on the development process for their recommen-
dations, including the process of the evidence review [27,
28, 43, 44], this development process does not seem to have
been followed in their study (Tables 2 and 3). Nonetheless,
when appraising the review, we considered the USPSTF
methodology descriptions current for that period of time,
described elsewhere [27, 28, 43, 44] (Table 3). Otherwise,
the review would have attained an even lower score. As the
review was published in 2004, the present USPSTF meth-
odology of guideline development, improved subsequently
in 2007 and 2008 [58–60], was not analyzed. It also means
that the current (2012) USPSTF recommendations against
scoliosis screening are based on the outdated methodology
of the USPSTF guideline development.
Finally, in the USPSTF ‘‘review of the process’’ paper
the authors say that comprehensive systematic reviews are
‘‘long, detailed reports of interest to a minority of readers
and of limited value to busy clinicians’’ [44]. It is difficult
to agree with this notion, as researchers, clinicians, com-
missioners and service users routinely make use of con-
clusions/recommendations from systematic reviews (e.g.
Cochrane reviews with separately published summaries).
In fact, systematic reviews are considered to be equivalent
to research studies that produce the highest level of evi-
dence according not only to OCEBM [57] and NHMRC
[56] but to numerous other organizations. Additionally, the
detailed guidelines for reporting explicit systematic
reviews of different types of studies have been in use (such
as QUORUM (1999) [61], then PRISMA (2009) [38],
MOOSE (2000) [62], and reporting guidelines from the US
Institute of Medicine (2011) [63]).
The authors of the Italian guidelines (2005) [18], rec-
ommending for school screening, reported on a systematic
analysis of the literature. It achieved an AMSTAR score of
2 (Table 3). A classification of the levels of evidence is
provided in this paper, including expert opinions. Within
these recommendations the evidence for scoliosis screen-
ing was classified as ‘‘E2: fair scientific consensus’’ [18]. In
brief, the document provides a recommendation on
screening for scoliosis driven from a consensus of a panel
of experts, rather than on a systematic analysis of available
evidence.
Strengths and limitations of the paper
The database search was supplemented with an inspection
of dedicated registries as well as websites of organizations
(e.g. International Network of the Agencies of Health
Technology Assessment). This resulted in retrieving
important publications (UK NSC [1], NHMRC [3] and
MaHTAS [16]) not indexed in major databases (as reported
in detail in Fig. 3) and omitted in recent reviews [4, 64,
65]. Reference lists of publications that were retrieved were
also hand searched. Potential authors of unpublished data
were not contacted, as the aim of this study was to appraise
published systematic reviews rather than performing a
meta-analysis of primary studies. The findings from the
grey literature search revealed that another systematic
review was currently in press [51]. Another limitation to
this paper was the fact that the papers included within this
review were not fully congruent with regard to the research
objectives, questions posed, strategies of review develop-
ment and reporting. We believe that selection bias was
unlikely in this study as only reviews meeting the specified
inclusion criteria were selected.
Finally, as to our knowledge this is the first evidence-
based appraisal of systematic reviews addressing school
screening for scoliosis, the findings of this review could not
be compared to similar reports.
Conclusions
The results found within this paper appear on the surface to
be very controversial. However, further detailed inquiry
based on in-depth evaluations of the methodological
quality of included papers within this reviews provide
much needed clarification. The most recent and current
reviews provided by Fong et al. in 2010 and Sabirin et al. in
2009 both of which scored a moderate quality 6 made
recommendations to continue school screening programs.
These reviews were based on papers that were current, and
most crucially were evaluated for their methodological
quality so that readers can be assured of the reliability and
validity of their results and conclusions.
The results presented within our evaluation suggest that
many of the recommendations made against school
screening are based on research papers that are over
10 years old and are, therefore, outdated. More to the point
and of utmost importance, most of these recommendations
did not evaluate the methodological quality of the papers
they included within their reviews. Thus it is impossible to
know whether these results and consequently their rec-
ommendations are truly valid and can reliably and justifi-
ably be applied to clinical practice. Until such time,
therefore, we suggest that the recommendations based on
low-quality reviews need to be interpreted with caution.
Implications for research and practice
There is an urgent need for high-quality primary studies to
be conducted on school screening for scoliosis to provide a
definitive answer to this very important question. Although
very difficult to conduct and not unanimously recom-
mended in cases of school screening programs (Box 3,
Fong et al. [32]), RCTs are indicated in the latest
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classifications of the Hierarchy of Evidence as the second
highest level of evidence from primary diagnostic studies
which investigate important patient outcomes [66]. The
first or highest level of evidence is systematic reviews of
such papers. In practice, however, we acknowledge that an
RCT comparing a group undergoing school screening to
one not undergoing screening would be very difficult if not
impossible to conduct. Whilst Fong recommended retro-
spective studies, the Cochrane Back Review Group does
not currently recognize such research designs to be of
sufficiently good quality to be included within a Cochrane
back review due to the high degree of error resulting from
bias and confounding variables [67]. What we would rec-
ommend, however, are PROSPECTIVE cohort studies with
a control group, with participants matched for age, gender
and other key variables.
In brief, once a number of prospective studies with a
control group have been conducted then well-conducted
systematic reviews which are crucially needed can be
carried out. Standards similar to those found within the
Cochrane collaboration and other similar organizations
would need to be followed to provide the much needed
reliable and trustworthy evidence for researchers, clini-
cians, commissioners and most importantly for the patients
and families concerned.
Protocol registration
This paper reports on a section of an overview of sys-
tematic reviews regarding nonsurgical management of
idiopathic scoliosis, including screening and is registered at
PROSPERO, CRD York, CRD42013003538.
Conflict of interest None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. [No authors listed] (2009) Screening for adolescent scoliosis.
External review against programme appraisal criteria for the UK
National Screening Committee (UK NSC). Bazian Ltd. http://
www.screening.nhs.uk/scoliosis. Accessed 11 June 2013
2. Labelle H, Richards SB, De Kleuver M, Grivas TB, Luk KD,
Wong HK, Thometz J, Beause´jour M, Turgeon J, Fong DY
(2013) Screening for adolescent idiopathic scoliosis: an infor-
mation statement by the scoliosis research society international
task force. Scoliosis 8:17
3. National Health and Medical Research Council (2002) Child
health screening and surveillance: a critical review of the
evidence. Centre for Community Child Health, Royal Children’s
Hospital Melbourne
4. Linker BA (2012) A dangerous curve. The role of history in
America’s scoliosis screening programs. Am J Public Health
102:1106–1116
5. Taylor TK, Bushell G, Ghosh P (1978) School screening for
scoliosis: a Pandora’s box. Aust N Z J Surg 48:2–3
6. Burwell G (1988) The British decision and subsequent events.
Spine 13:1192–1194
7. Winter RB, Lonstein JB (1997) To brace or not to brace: the true
value of school screening. Spine 22:1283–1284
8. Dickson RA, Weinstein SL (1999) Bracing (and screening)—yes
or no? J Bone Jt Surg Br 81:193–198
9. Winter RB, Banta JV, Engler G, Scoliosis Research Society
(1995) Screening for scoliosis. JAMA 273:185–186
10. Sox HC Jr, Woolf SH, US Preventive Services Task Force (1995)
In reply (Screening for scoliosis). JAMA 273:186
11. Bunnell WP (2005) Selective screening for scoliosis. Clin Orthop
Relat Res 434:40–45
12. Bunge EM, de Koning HJ (2006) Selective screening for scoli-
osis. Clin Orthop Relat Res 445:277–278
13. Bunge EM, Juttmann RE, van Biezen FC, Creemers H, Hazeb-
roek-Kampschreur AAJM, Luttmer BCF, Wiegersma A, de
Koning H, for the Netherlands Evaluation Study for Screening for
Scoliosis (NESCIO) group (2008) Estimating the effectiveness of
screening for scoliosis: a case-control study. Pediatrics 121:9–14
14. Richards BS, Beaty JH, Thompson GH, Willis RB (2008) Esti-
mating the effectiveness of screening for scoliosis. Pediatrics
121:1296–1297
15. School Health Connections/Healthy Start Office (2007) The
Standards for Scoliosis Screening in California Public Schools.
California Department of Education
16. Sabirin J, Buang SN (2009) School scoliosis screening pro-
gramme. Health Technology Assessment Report, Health Tech-
nology Assessment Section, Ministry of Health Malaysia, MOH/
P/PAK/186.09 (TR). www.moh.gov.my/health_assessments/58
17. Richards BS, Vitale M Screening for Idiopathic Scoliosis in
Adolescents. AAOS-SRS-POSNA-AAP Position Statement.
http://www.aaos.org/about/papers/position/1122.asp. Accessed 13
June 2013
18. Negrini S, Aulisa L, Ferraro C, Fraschini P, Masiero S, Simo-
nazzi P, Tedeschi C, Venturin A (2005) Italian guidelines on
rehabilitation treatment of adolescents with scoliosis or other
spinal deformities. Eura Medicophys 41:183–201
19. Grivas TB, Wade MH, Negrini S, O’Brien JP, Maruyama T,
Hawes MC, et al (2007) SOSORT consensus paper: school
screening for scoliosis. Where are we today? Scoliosis 2:17 http://
www.scoliosisjournal.com/content/2/1/17
20. Negrini S, Aulisa AG, Aulisa L, Circo AB, de Mauroy JC,
Durmala J, et al (2012) 2011 SOSORT guidelines: Orthopaedic
and rehabilitation treatment of idiopathic scoliosis during growth.
Scoliosis 7:3 http://www.scoliosisjournal.com/content/7/1/3
21. UK Screening Portal, UK National Screening Committee, UK
National Screening Policy Database. Scoliosis. http://www.
screening.nhs.uk/policydb.php./; http://www.screening.nhs.uk/
scoliosis. Accessed 15 June 2013
22. US Preventive Services Task Force (2004) Screening for idio-
pathic scoliosis in adolescents: recommendation statement. http://
www.ahrq.gov. Accessed 15 Jan 2013
23. American Academy of Family Physicians (2012) Summary of
recommendations for clinical preventive services. American
Academy of Family Physicians (AAFP), Leawood, p 18
24. Agency for Healthcare Research and Quality (2012) Guide to
Clinical Preventive Services. AHRQ Publication No. 12-05154,
Rockville, p. 71. www.ahrq.gov/clinic/pocketgd.htm. Accessed
20 Feb 2013
Eur Spine J (2014) 23:2572–2585 2583
123
25. US Preventive Services Task Force (2012) Recommendations.
http://www.uspreventiveservicestaskforce.org/recommendations.
htm. Accessed 23 Feb 2013
26. Canadian Task Force on Periodic Health Examination (1979) The
periodic health examination. CMA J 121:1193–1254
27. US Preventive Services Task Force (1993) Screening for adoles-
cent idiopathic scoliosis: policy statement. JAMA 269:2664–2666
28. US Preventive Services Task Force (1996) Guide to Clinical
Preventive Services: Report of the U.S. Preventive Services Task
Force. 2nd edn. US Department of Health and Human Services,
Washington (DC). www.ncbi.nlm.nih.gov/books/NBK15435/
29. Goldbloom R (1994) Screening for Adolescent Idiopathic Scoli-
osis. In: Canadian Task Force on Periodic Health Examination.
The Canadian guide to clinical preventive health care. Minister of
Public Works and Government Services Canada, Ottawa. http://
canadiantaskforce.ca/wp-content/uploads/2013/03/Chapter31_
idio_adoles_scoliosis94.pdf?9d7bd4
30. [No authors listed] (2004) Screening for idiopathic scoliosis in
adolescents: a brief evidence update for the U.S. preventive ser-
vices task force. AHRQ Pub. No. 05-0568-B http://www.uspre
ventiveservicestaskforce.org/3rduspstf/scoliosis/scolioup.pdf
31. Richards BS, Vitale MG (2008) Screening for idiopathic scoliosis
in adolescents. An information statement. J Bone Jt Surg Am
90:195–198
32. Fong DY, Lee CF, Cheung KM, Cheng JC, Ng BK, Lam TP, Mak
KH, Yip PS, Luk KD (2010) A meta-analysis of the clinical
effectiveness of school scoliosis screening. Spine 35:1061–1071
33. Larson N (2011) Early onset scoliosis: what the primary care
provider needs to know and implications for practice. J Am Acad
Nurse Pract 23:392–403
34. Wilkinson J, Bass C, Diem S, Gravley A, et al (2012) Institute for
Clinical Systems Improvement. Preventive Services for Children
and Adolescents. Bloomington (MN): Institute for Clinical Sys-
tems Improvement (ICSI); p 87 http://bit.ly.PrevServKids0912
35. Sabirin J, Bakri R, Buang SN, Abdullah AT, Shapie A (2010)
School scoliosis screening programme—a systematic review.
Med J Malaysia 65:261–267
36. Petticrew M (2003) Why certain systematic reviews reach
uncertain conclusions. BMJ 326:756–758
37. Smith V, Devane D, Begley CM, Clarke M (2011) Methodology
in conducting a systematic review of systematic reviews of
healthcare interventions. BMC Med Res Methodol 11:15
38. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred
reporting items for systematic reviews and meta-analyses: the
PRISMA statement. BMJ 339:b2535
39. [No authors listed] (2005) Glossary of terms in the cochrane
Collaboration. version 4.2.5., The cochrane collaboration
40. Connor Gorber S, Singh H, Pottie K, Jaramillo A, Tonelli M
(2012) Process for guideline development by the reconstituted
Canadian Task Force on Preventive Health Care. CMAJ
184:1575–1581
41. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N,
Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM (2007)
Development of AMSTAR: a measurement tool to assess the
methodological quality of systematic reviews. BMC Med Res
Methodol 7:10
42. Popovic I, Windsor B, Jordan V, Showell M, Shea B, Farquhar
CM (2012) Methodological quality of systematic reviews in
subfertility: a comparison of two different approaches. PLoS One
7(12):e50403
43. Sox HC Jr, Berwick DM, Berg AO et al (1993) Screening for ado-
lescent idiopathic scoliosis: review article. JAMA 269:2667–2672
44. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teu-
tsch SM, Atkins D (2001) Current methods of the US Preventive
Services Task Force: a review of the process. Am J Prev Med
20(3 Suppl):21–35
45. [No authors listed] (2011) Knowledge update on screening for
scoliosis (February 2011). Available at http://www.screening.nhs.
uk/scoliosis. Accessed 11 June 2013
46. [No authors listed] (2011) Appendix to knowledge update on
screening for scoliosis. http://www.screening.nhs.uk/scoliosis.
Accessed 11 June 2013
47. [No authors listed] (2011) August 2011 update to the February
2011 Knowledge update on screening for scoliosis. http://www.
screening.nhs.uk/scoliosis. Accessed 11 June 2013
48. [No authors listed] (2002) Child Health Screening and Surveil-
lance: Supplementary Document—Context And Next Steps. The
Child and Youth Health Inter-governmental Partnership, National
Public Health Partnership. http://www.nphp.gov.au. Accessed 31
May 2013
49. Lee CF (2009) School screening and curve progression in ado-
lescent idiopathic scoliosis. Dissertation, University of Hong
Kong
50. Beause´jour M, Goulet L, Parent S, Feldman DE, Turgeon I, Roy-
Beaudry M, Sosa JF, Labelle H; Members of the Quebec Scoli-
osis Society and of the Canadian Paediatric Spinal Deformities
Study Group (2013) The effectiveness of scoliosis screening
programs: methods for systematic review and expert panel rec-
ommendations formulation. Scoliosis 8:12
51. Feldman D, Beause´jour M, Sosa JF, Goulet L, Parent S, Labelle
H; and the members of the Quebec Scoliosis Society and the
Canadian Pediatric Spinal Deformities Study Group (2014) Cost
effectiveness of school screening for scoliosis: a systematic
review. Int J Child Adolesc Health 7(1). Available at https://
www.novapublishers.com/catalog/product_info.php?products_
id=46272. Accessed 19 Apr 2014
52. Grant MJ, Booth A (2009) A typology of reviews: an analysis of
14 review types and associates methodologies. HILJ 26:91–108
53. Ioannidis JPA (2009) Integration of evidence from multiple meta-
analyses: a primer on umbrella reviews, treatment networks and
multiple treatments meta-analyses. CMAJ 181:488–493
54. Moe RH, Haavardsholm EA, Christie A, Jamtvedt G, Dahm KT,
Hagen KB (2007) Effectiveness of nonpharmacological and
nonsurgical interventions for hip osteoarthritis: an umbrella
review of high quality systematic reviews. Phys Ther
87:1716–1727
55. Rowe DE, Bernstein SM, Riddick MF, Adler F, Emans JB,
Gardner-Bonneau D (1997) A meta-analysis of the efficacy of
non-operative treatments for idiopathic scoliosis. J Bone Jt Surg
Am 79:664–674
56. Centre for Evidence-Based Medicine, Oxford, UK (2011) Levels
of evidence for primary research question. www.cebm.net.
Accessed 15 May 2013
57. National Health and Medical Research Council (2009) NHMRC
Levels of evidence and grades of recommendations for devel-
opers of guidelines. http://www.nhmrc.gov.au/guidelines/resour
ces-guideline-developers. Accessed 30 May 2013
58. Guirguis-Blake J, Calonge N, Miller T, Siu A, Teutsch S,
Whitlock E, U.S. Preventive Services Task Force (2007) Current
processes of the U.S. Preventive Services Task Force: refining
evidence-based recommendation development. Ann Intern Med
147:117–122
59. Barton MB, Miller T, Wolff T, Petitti D, LeFevre M, Sawaya G,
Yawn B, Guirguis-Blake J, Calonge N, Harris R, U.S. Preventive
Services Task Force (2007) How to read the new recommenda-
tion statement: methods update from the U.S. Preventive Services
Task Force. Ann Intern Med 147(2):123–127
60. U.S. Preventive Services Task Force Procedure Manual (2008)
AHRQ Publication No. 08-05118-EF. http://www.uspreventive
servicestaskforce.org/uspstf08/methods/procmanual.htm
61. Moher D, Cook D, Eastwood S, Olkin I, Rennie D, Stroup DF, for
the QUORUM Group (2009) Improving the quality of reports of
2584 Eur Spine J (2014) 23:2572–2585
123
meta-analyses of randomised controlled trials: the QUORUM
statement. Lancet 354:1896–1900
62. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD,
Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, for the
Meta-analysis of Observational Studies in Epidemiology
(MOOSE) Group (2000) Meta-analysis of observational studies in
epidemiology. A proposal for reporting. JAMA 283:2008–2012
63. IOM (Institute of Medicine) (2011) Standards for reporting sys-
tematic reviews. In: Finding What Works in Health Care: Stan-
dards for Systematic Reviews. The National Academies Press,
Washington DC, Chapter 5
64. Hresco MT (2013) Idiopathic scoliosis in adolescents. N Engl J
Med 368:834–841
65. Altaf F, Gibson A, Dannawi Z, Noordeen H (2013) Adolescent
idiopathic scoliosis. BMJ 2013(346):f2508
66. The Joanna Briggs Institute Levels of Evidence and Grades of
Recommendation Working Party (2014) Supporting Document
for the Joanna Briggs Institute Levels of Evidence and Grades of
Recommendation. The Joanna Briggs Institute. http://joannab
riggs.org/assets/docs/approach/Levels-of-Evidence-Supporting
Documents.pdf. Accessed 15 March 2014
67. Bettany-Saltikov J, Weiss HR, Chockalingam N, Taranu R,
Srinivas S, Hogg J, Whittaker V (2013) Kalyan RV (2013) Sur-
gical versus non-surgical interventions in patients with adolescent
idiopathic scoliosis (Protocol). Cochrane Database of Systematic
Reviews 7:CD010663
Eur Spine J (2014) 23:2572–2585 2585
123
